Stage IIA Pancreatic Cancer AJCC v8
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00023 | Asparaginase Escherichia coli | 1 | Recruiting | 1 |
DB11105 | Benzalkonium | 1 | Recruiting | 1 |
DB14730 | Calaspargase pegol | 1 | Recruiting | 1 |
DB01373 | Calcium | 1 | Completed | 1 |
DB14531 | Carbonate ion | 1 | Recruiting | 1 |
DB05239 | Cobimetinib | 1 | Recruiting | 1 |
DB11841 | Entinostat | 1 | Withdrawn | 1 |
DB00678 | Losartan | 1 | Recruiting | 1 |
DB16239 | Molibresib | 1 | Withdrawn | 1 |
DB06816 | Pyrvinium | 1 | Recruiting | 1 |
DB15366 | SOR-C13 | 1 | Completed | 1 |
DB00544 | Fluorouracil | 1 / 2 | Recruiting | 1 |
DB00441 | Gemcitabine | 1 / 2 | Recruiting | 1 |
DB00762 | Irinotecan | 1 / 2 | Recruiting | 1 |
DB00650 | Leucovorin | 1 / 2 | Recruiting | 1 |
DB00526 | Oxaliplatin | 1 / 2 | Recruiting | 1 |
DB01229 | Paclitaxel | 1 / 2 | Recruiting | 1 |
DB00062 | Albumin human | 2 | Recruiting | 1 |
DB11714 | Durvalumab | 2 | Recruiting | 1 |
DB11717 | Epacadostat | 2 | Withdrawn | 1 |
DB00441 | Gemcitabine | 2 | Recruiting | 1 |
DB09078 | Lenvatinib | 2 | Recruiting | 1 |
DB15088 | Oleclumab | 2 | Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Withdrawn | 1 |